Skip to main content

Table 3 Correlations the clinical characteristics among CCL19 and non-cirrhotic HCC in TCGA

From: In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC

Variables N Non-cirrhotic HCC
CCL19
Low/high expression case (n) p value
Gender
 Male 82 64/18 0.585
 Female 50 41/9
Age at diagnosis
 ≥ 60 80 68/12 0.054
 < 60 52 37/15
T stage
 T1/T2 97 76/21 0.846
 T3/T4 33 27/6
 TX 1 1/0
 NA 1 1/0  
N stage
 N0 91 73/18 0.853
 N1 1 1/0
 NX 40 31/9
M stage
 M0 90 74/16 0.178
 M1 4 2/2
 MX 38 29/9
Pathologic stage
 I/II 91 72/19 0.741
 III/IV 33 27/6
 NA 8 6/2
Vascular invasion
 None 87 69/18 1.000
 Micro 33 26/7
 Macro 6 5/1
 NA 6 5/1
HBV infection
 Yes 38 27/11 0.176
 No 88 72/16
 NA 6 6/0
HCV infection
 Yes 14 7/7 0.016
 No 112 92/20
 NA 6 6/0
  1. NA not applicable
  2. The significant p value is marked with italic type